Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore! Learn More →

← Back to all trials

Recruiting NCT05201781

A Long-term Study for Participants Previously Treated With Ciltacabtagene Autoleucel

Conditions: Multiple Myeloma

Sex: All

Ages: 18 Years – N/A

Healthy volunteers: No

Phase: PHASE4

Enrollment: 295

Sponsor: Janssen Research & Development, LLC

Location: Mayo Clinic Cancer Center-Scottsdale Phoenix Arizona

Summary

The purpose of this study is to collect long-term follow-up data on delayed adverse events after administration of ciltacabtagene autoleucel (cilta-cel), and to characterize and understand the long-term safety profile of cilta-cel.

Eligibility Criteria

Inclusion Criteria: * Participants who have received at least one dose of cilta-cel in a Company-sponsored clinical study * Participants who have provided informed consent for this study

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05201781). StuddyBuddy aggregates publicly available trial information.